Ozempic Breast — The Latest Side Effect of a Popular Weight Loss Drug
Aesthetics Advisor
JUNE 3, 2024
Both drugs come from the Danish pharmaceutical company Novo Nordisk, whose market capitalization has soared to $609 billion, surpassing Tesla’s valuation by $40 billion. Leading this trend is semaglutide, better known by its brand names Ozempic, a diabetes medication, and Wegovy, a higher-dose variant specifically for weight loss.
Let's personalize your content